2017.9.1

The Startup of atDose

atDose was Founded on September 1, 2017 in Yokohama City, Kanagawa, Japan. Here's our logo at the time of our founding.

2017.9.1

The Startup of atDose

2018.1.22-2.4

Selected for SV members of Sido-2017

The CEO of atDose was selected as one of the 20 members of "Sido Next Innovator 2017" sponsored by the Ministry of Economy, Trade and Industry in Silicon Valley.

2018.1.22-2.4

Selected for SV members of Sido-2017

2018.9.1

Established the Laboratory at KBIC

Just one year after the company's launch, we set up a development base at the KBIC incubation facility in Kawasaki City.

2018.9.1

Established the Laboratory at KBIC

2019.1.18

Granted to NEDO NEP

CEO was granted to the "Research and Development Venture Support Project" by NEDO. NEDO is a national research and development agency that creates innovation by promoting technological development necessary for realization of a sustainable society.

2019.1.18

Granted to NEDO NEP

2019.6.12

Granted to KISTEC Research Proposal

The project has been selected for the "Research to Promote Industry-Academia-Government Collaboration" by the Kanagawa Institute of Science and Technology (KISTEC), a local independent administrative agency.

2019.6.12

Granted to KISTEC Research Proposal

2019.7.4

Selected for the ”The Springboard™ Program in Yokohama"

atDose has been selected as one of the four companies to be supported by the City of Yokohama's "The Springboard™ Program in Yokohama".

2019.7.4

Selected for the ”The Springboard™ Program in Yokohama"

2019.7.25

Selected for the Yokohama Acceleration Program

We were selected as one of eight companies in the Yokohama Acceleration Program, which supports the growth and development of venture businesses.

2019.7.25

Selected for the Yokohama Acceleration Program

2019.9.21

Company Award in TECH PLANTER

atDose was selected as one of the 12 finalist teams for the TECH PLANTER Biotech Grand Prix and received the Corporate Award "Mitsui Chemicals Award" at the final round.

2019.9.21

Company Award in TECH PLANTER

2019.10.10

The three companies start development for animal experiments

joint-research-image

atDose Co., Ltd. , Phenovance Research & Technology, LLC and Teslasheet Inc. have signed a joint research agreement starting October 10, 2019.

2019.10.10

The three companies start development for animal experiments

2019.12.26

Selected YOXO Accelerator Program

atDose was selected as one of the 12 companies in the YOXO Accelerator Program of Yokohama City.

2019.12.26

Selected YOXO Accelerator Program

2020.2.22

Audience Award at Yokohama Business Grand Prix

At the Yokohama Business Grand Prix, held in Yokohama Minato Mirai, we received the Audience Award, which was decided by the audience's vote.

2020.2.22

Audience Award at Yokohama Business Grand Prix

2020.3.29

Broadcast on the TV show "Change the World"

atDose and our mobile drip device were featured on TV Tokyo and BS Tele-to "Change the World - Vision to Build the Future".

2020.3.29

Broadcast on the TV show "Change the World"

2020.7.22

Medical device manufacturing and marketing license

HP背景3

We obtained a license for the manufacture and sale of medical devices from Kanagawa Prefecture. Type of License: Class 1 Medical Device Marketing Authorization (All three medical device classifications can be handled) MAH No. 14B1X10026

2020.7.22

Medical device manufacturing and marketing license

2020.8.6

Distributed in three products: atDose Core, Mobile, and Multi

atDose Mobile Image

We have begun development of the atDose Multi, a miniaturized syringe pump used for intravenous (IV) medication. We will continue to develop three products: Core, Mobile, and Multi.

2020.8.6

Distributed in three products: atDose Core, Mobile, and Multi

2020.8.31

Raised 55.5 million yen

DEFTA Healthcare Technologies, L.P. (based in the U.S., Israel, Japan, Hong Kong, etc. / GP: DEFTA Capital, Inc. etc.; hereinafter referred to as "DHCT") and private investors raised 55.5 million yen through a private placement of new shares.

2020.8.31

Raised 55.5 million yen

2020.9.2

Start development of beauty equipment with Think-Lands

atDose and Think-Land will enter into a joint research agreement from September 2, 2020, to solve the challenges of the beauty industry.

2020.9.2

Start development of beauty equipment with Think-Lands

2020.10.28

Logo and website update

The logo was redesigned and the website was updated.

2020.10.28

Logo and website update

2021.8.31

Raised 40 million yen

DEFTA Healthcare Technologies, L.P. (based in the U.S., Israel, Japan, Hong Kong, etc. / GP: DEFTA Capital, Inc. etc.; hereinafter referred to as "DHCT") raised 40 million yen through a private placement of new shares.

2021.8.31

Raised 40 million yen

2021.11.04

Selected by JETRO Partners with Top Accelerators for Startup City Acceleration Program

JETRO will host an online acceleration program in partnership with the Cabinet Office of Japan from October 2021 to March 2022.  In this program, JETRO will collaborate with 6 major accelerators to cultivate the growth of Japanese startup ecosystems. We have been selected as one of the 10 companies for the Bio/Healthcare Course by CIC.

2021.11.04

Selected by JETRO Partners with Top Accelerators for Startup City Acceleration Program

2022.1.25

Awarded the Kanagawa Prefecture Governor's Prize at the Kanagawa Business Audition

We received the Kanagawa Prefecture Governor's Award at the final judging of the Kanagawa Business Audition 2022, a business contest having a long history with 26 years.

2022.1.25

Awarded the Kanagawa Prefecture Governor's Prize at the Kanagawa Business Audition